Daily administration of MGCD265 to patients with solid tumors in a dose-escalation phase I study (study 265-101).


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Drouin, MA; Kollmannsberger, CK; Uronis, HE; Martell, RE; Wang, J; Dubay, M; Dupont, I; Besterman, JM; Hurwitz, H; Shapiro, G

Published Date

  • May 20, 2010

Published In

Volume / Issue

  • 28 / 15_suppl

Start / End Page

  • 3106 - 3106

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2010.28.15_suppl.3106